How to buy Envista Holdings Corporation stock | $43.64

Envista Holdings Corporation is a medical instruments & supplies business based in the US. Envista Holdings Corporation shares (NVST) are listed on the NYSE and all prices are listed in US Dollars. Envista Holdings Corporation employs 12,400 staff and has a trailing 12-month revenue of around 0.00.

Envista Holdings Corporation stock price (NYSE: NVST)

Use our graph to track the performance of NVST stocks over time.

Envista Holdings Corporation shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$43.64
52-week range	$21.75 - $46.52
50-day moving average	$42.93
200-day moving average	$41.23
Wall St. target price	$50.60
PE ratio	57.9396
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.73

Buy Envista Holdings Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Envista Holdings Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Envista Holdings Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Envista Holdings Corporation price performance over time

Historical closes compared with the close of $43.64 from 2021-05-28

1 week (2021-07-21)	N/A
1 month (2021-07-01)	-0.30%
3 months (2021-04-30)	0.83%
6 months (2021-01-28)	N/A

1 year (2020-07-28)	N/A
2 years (2019-07-28)	N/A
3 years (2018-07-28)	N/A
5 years (2016-07-28)	N/A

Is Envista Holdings Corporation under- or over-valued?

Valuing Envista Holdings Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Envista Holdings Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Envista Holdings Corporation's P/E ratio

Envista Holdings Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 58x. In other words, Envista Holdings Corporation shares trade at around 58x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Envista Holdings Corporation's EBITDA

Envista Holdings Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $474 million.

The EBITDA is a measure of a Envista Holdings Corporation's overall financial performance and is widely used to measure a its profitability.

Envista Holdings Corporation financials

Revenue TTM	$2.4 billion
Operating margin TTM	14%
Gross profit TTM	$1.2 billion
Return on assets TTM	3.4%
Return on equity TTM	3.38%
Profit margin	5%
Book value	$23.33
Market capitalisation	$6.8 billion

TTM: trailing 12 months

Shorting Envista Holdings Corporation shares

There are currently 9.8 million Envista Holdings Corporation shares held short by investors – that's known as Envista Holdings Corporation's "short interest". This figure is 5.6% up from 9.3 million last month.

There are a few different ways that this level of interest in shorting Envista Holdings Corporation shares can be evaluated.

Envista Holdings Corporation's "short interest ratio" (SIR)

Envista Holdings Corporation's "short interest ratio" (SIR) is the quantity of Envista Holdings Corporation shares currently shorted divided by the average quantity of Envista Holdings Corporation shares traded daily (recently around 1.4 million). Envista Holdings Corporation's SIR currently stands at 7.17. In other words for every 100,000 Envista Holdings Corporation shares traded daily on the market, roughly 7170 shares are currently held short.

However Envista Holdings Corporation's short interest can also be evaluated against the total number of Envista Holdings Corporation shares, or, against the total number of tradable Envista Holdings Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Envista Holdings Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Envista Holdings Corporation shares in existence, roughly 60 shares are currently held short) or 0.0615% of the tradable shares (for every 100,000 tradable Envista Holdings Corporation shares, roughly 62 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Envista Holdings Corporation.

Find out more about how you can short Envista Holdings Corporation stock.

Envista Holdings Corporation share dividends

We're not expecting Envista Holdings Corporation to pay a dividend over the next 12 months.

Envista Holdings Corporation overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.

Frequently asked questions

What percentage of Envista Holdings Corporation is owned by insiders or institutions?
Currently 0.217% of Envista Holdings Corporation shares are held by insiders and 109.242% by institutions. How many people work for Envista Holdings Corporation?
Latest data suggests 12,400 work at Envista Holdings Corporation. When does the fiscal year end for Envista Holdings Corporation?
Envista Holdings Corporation's fiscal year ends in December. Where is Envista Holdings Corporation based?
Envista Holdings Corporation's address is: Building E, Brea, CA, United States, 92821-6208 What is Envista Holdings Corporation's ISIN number?
Envista Holdings Corporation's international securities identification number is: US29415F1049 What is Envista Holdings Corporation's CUSIP number?
Envista Holdings Corporation's Committee on Uniform Securities Identification Procedures number is: 29415F104